Otonomy Holds Investor and Analyst Day and Provides Corporate Update

Back to Jobs

SAN DIEGO , Oct. 07, 2016 (GLOBE NEWSWIRE) — Otonomy, Inc. (Nasdaq:OTIC), a biopharmaceutical company focused on the development and commercialization of innovative therapeutics for diseases and disorders of the ear, today held an investor and analyst day which included an update on the commercial

Apply Now